# Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

> **NCT00201240** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 47 (actual)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **BIOLOGICAL:** CD34+ selection with CliniMACS device

## Key facts

- **NCT ID:** NCT00201240
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201240, "Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00201240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*